Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
The American Journal of Physiology
|
January 1, 1990
Use of a variable tracer infusion method to determine glucose turnover in humans
J M Molina, A D Baron, S V Edelman, et al.
Obesity Science & Practice
|
October 27, 2017
Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence
G S Carls, R Tan, J Y Zhu, et al.
Journal of Diabetes and Its Complications
|
August 26, 2000
Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy
Y Harati, C Gooch, M Swenson, et al.
Diabetes, Obesity & Metabolism
|
October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
L L Ilag, M A Deeg, T Costigan, et al.
Diabetes Care
|
October 17, 1998
The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors
W C Duckworth, C D Saudek, A Giobbie-Hurder, et al.
JAMA
|
October 23, 1996
Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group
C D Saudek, W C Duckworth, A Giobbie-Hurder, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
The American Journal of Physiology
|
January 1, 1990
Use of a variable tracer infusion method to determine glucose turnover in humans
J M Molina, A D Baron, S V Edelman, et al.
Obesity Science & Practice
|
October 27, 2017
Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence
G S Carls, R Tan, J Y Zhu, et al.
Journal of Diabetes and Its Complications
|
August 26, 2000
Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy
Y Harati, C Gooch, M Swenson, et al.
Diabetes, Obesity & Metabolism
|
October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
L L Ilag, M A Deeg, T Costigan, et al.
Diabetes Care
|
October 17, 1998
The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors
W C Duckworth, C D Saudek, A Giobbie-Hurder, et al.
JAMA
|
October 23, 1996
Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group
C D Saudek, W C Duckworth, A Giobbie-Hurder, et al.
Page
of 4